Mindset Pharma Announces Positive Preclinical Results of Its Proprietary Next Generation DMT & 5-MeO-DMT Compounds Apr 29, 2021
PharmaTher Expands Patent Portfolio for Ketamine and Repurposing of Psychedelics with panaceAI™ Apr 27, 2021
PsyBio and Miami University Broaden Partnership Agreement to Continued Advancement of its Neuropsychiatric Drug… Apr 26, 2021
Numinus Announces Listing of Warrants and Change of Trading Symbol for Previously Listed Warrants Apr 26, 2021
Numinus Executives Dish on Details of Its Upcoming Phase 1 Clinical Trial Using Natural Psilocybin Apr 26, 2021
